Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002431334 | SCV002743624 | uncertain significance | Cardiovascular phenotype | 2019-04-12 | criteria provided, single submitter | clinical testing | The p.D9091G variant (also known as c.27272A>G), located in coding exon 109 of the TTN gene, results from an A to G substitution at nucleotide position 27272. The aspartic acid at codon 9091 is replaced by glycine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be benign and unknown by PolyPhen and SIFT in silico analyses, respectively. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |